Why the study?
Does captopril pretreatment alter the natriuretic and hypotensive response to ANP in anaesthetized adult Münich-Wistar rats?
Does captopril pretreatment alter the natriuretic and hypotensive response to ANP in anaesthetized adult Münich-Wistar rats?
Converting enzyme inhibition with captopril does not interfere with the natriuretic or hypotensive effects of ANP, suggesting angiotensin II does not mediate these acute effects.
Answers are grounded in this paper and cite their sources.
ANP responses persist after captopril in rats; leaves open angiotensin II mediation in human ANP effects.
Effects of atrial natriuretic peptide (ANP) during converting enzyme inhibition. Acta Physiol Scand 130 , 393–399. Received 1 December 1986, accepted 10 February 1987. ISSN 0001–6772. Department of Physiology & Medical Biophysics, Biomedical Centre, University of Uppsala, Sweden. Studies were performed on anaesthetized adult Münich‐Wistar rats to investigate the role of angiotensin 11 in the natriuretic response to synthetic atrial natriuretic peptide (ANP, 28 amino acids). For this purpose the whole kidney glomerular filtration rate (GFR) and urinary excretion of electrolytes were measured in groups of animals pretreated with the converting enzyme inhibitor captopril (3 mg h ‐1 kg ‐1 body wt) or vehicle and then given a continuous intravenous infusion of ANP at 10 μg h ‐1 kg ‐1 body wt. In the vehicle‐pretreated animals, 45 min of ANP infusion did not change GFR (control value 1.17 ± 0.11, experimental value 1.17 ± 0.06 ml min ‐1 g ‐1 kidney wt). Sodium excretion ( U Na V ) increased more than three‐fold from 0.036 ± 0.010 to 0.134 ± 0.058 pmol min ‐1 g ‐1 kidney wt ( p 0.05) and potassium excretion ( U K V ) increased from 0.481 ± 0.055 to 0.946 ± 0.068 μmol min ‐1 g ‐1 kidney wt ( P 0.05). Urine osmolality (U O sm ) remained unchanged, while the blood pressure (BP) decreased by 15%. In animals pretreated with captopril, ANP infusion led to a decrease in GFR from 1.27 ± 0.11 to 1.05 ± 0.09 ml min ‐1 g ‐1 kidney wt ( P 0.05). Despite this effect, U Na V increased more than two‐fold from 0.076 ± 0.020 to 0.193 ± 0.087 μmol min ‐1 g ‐1 kidney wt ( P 0.05). The U K V was not statistically significantly elevated (change from 0.623 ± 0.156 to 0.859 ± 0.146 μmol min ‐1 g ‐1 kidney wt) and U Osm remained unaltered, while BP decreased by 15% ( P 0.05). The captopril‐pretreated animals had a higher U Na V value during the control period than vehicle‐pretreated ones, but there was no statistical difference in this variable between the groups after ANP infusion. The captopril treatment decreased BP by 6%. It is concluded that converting enzyme inhibition induced by captopril does not interfere with either the natriuretic or with the hypotensive response to ANP, which suggests that angiotensin II does not participate in the generation of the acute effects of ANP. Atrial natriuretic peptide increases sodium excretion predominantly by affecting tubular transport processes, and not by increasing GFR.
No takes yet. Share an insight, caveat, or question.
Hansell et al. (1987) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: